Craig Beavers

1 week ago | pharmacytimes.com | Craig Beavers |BCPSAQ Cardiology |Aislinn Antrim

CommentaryPodcastJune 17, 2025Author(s):,Host Craig Beavers chats with Shannon Finks, PharmD, FCCP, BCPS, BCCP, AHSCP-CHC, president and director of pharmacy services at ZupMed in Memphis, Tennessee. Host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, CACP, chats with Shannon Finks, PharmD, FCCP, BCPS, BCCP, AHSCP-CHC, president and director of pharmacy services at ZupMed in Memphis, Tennessee.

3 weeks ago | pharmacytimes.com | Craig Beavers |BCPSAQ Cardiology |Aislinn Antrim

CommentaryPodcastJune 3, 2025Author(s):,Ralph Riello, PharmD, BCPS, a board-certified clinical pharmacy specialist at the Yale University School of Medicine, discusses challenges in implementation for novel cardiovascular treatments and interventions. Ralph Riello, PharmD, BCPS, a board-certified clinical pharmacy specialist at the Yale University School of Medicine, discusses challenges in implementation for novel cardiovascular treatments and interventions.

1 month ago | pharmacytimes.com | Craig Beavers |BCPSAQ Cardiology |Aislinn Antrim

Host Craig Beavers speaks with Orly Vardeny, PharmD, MS, a professor of medicine at the University of Minnesota. Vardeny discusses her own career path, the importance of mentors, and pharmacist involvement in clinical research, such as her work with the FINEARTS-HF study of finerenone in heart failure. Show Notes:

1 month ago | pharmacytimes.com | Aislinn Antrim |Craig Beavers |BCPS-AQ Cardiology

Host Craig Beavers spoke with Lavinia Salama, PharmD, clinical assistant professor at the University of Wyoming, about cardio-kidney-metabolic syndrome and how pharmacists can be at the forefront of serving patients. Salama also discusses her work in rural communities and why pharmacists are so crucial for those patients. Show Notes:

2 months ago | pharmacytimes.com | Craig Beavers |BCPS-AQ Cardiology |Aislinn Antrim

The RIVAWAR Trial and ACS Guidelines for LV ThrombusHost Craig Beavers spoke with Arthur Allen, PharmD, for the latest updates from the RIVAWAR trial and the newest ACS guidelines.